Primary Record
ioversol
- In stock
- 3,771 g
- Purity
- 99.8 %
- CAS
- 87771-40-2
Compound Identifiers & Properties
- CAS
- 87771-40-2
- PubChem CID
- 3741
- SMILES
- C(CO)N(C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I)C(=O)CO
- Canonical SMILES
- O=C(NCC(O)CO)c1c(I)c(C(=O)NCC(O)CO)c(I)c(N(CCO)C(=O)CO)c1I
Names & Synonyms
- ioversol
- Optiray
- 87771-40-2
- Ioversolum
- Optiray 320
- ioversolo
- joversol
- Optiray 160
- Optiray 240
- Optiray 300
- Optiray 350
- Ioversolum [Latin]
- LOVERSOL
- MP-328
- Optiray (TN)
- N3RIB7X24K
- IOVERSOL [USAN]
- RefChem:57669
- UNII-N3RIB7X24K
- DTXSID2045521
- IOVERSOL [INN]
- IOVERSOL [JAN]
- IOVERSOL [MI]
- AC1L1GLW
- AC1Q4PBO
- IOVERSOL [VANDF]
- Prestwick0_000878
- Prestwick1_000878
- Prestwick2_000878
- Prestwick3_000878
- GlyTouCan:G70941PS
- Ioversol [USAN:INN:BAN]
- IOVERSOL [MART.]
- MP 328
- D0U1ZD
- IOVERSOL [USP-RS]
- IOVERSOL [WHO-DD]
- C18H24I3N3O9
- Ioversol (JAN/USP/INN)
- SCHEMBL24711
- BSPBio_000955
- DTXCID0025521
- Ioversol [USAN:BAN:INN]
- Ioversol [USAN:USP:INN:BAN]
- SPBio_002876
- AMDBBAQNWSUWGN-UHFFFAOYSA-N
- IOVERSOL [ORANGE BOOK]
- BPBio1_001051
- orb1307046
- CHEMBL1200614
- IOVERSOL [USP MONOGRAPH]
- CHEBI:31717
- CTK3E8473
- BRN 7155654
- CID3741
- V08AB07
- MFCD00867959
- HMS1570P17
- HMS2097P17
- HMS3714P17
- HMS5084C11
- Pharmakon1600-01503837
- BCP11109
- CID:3741
- G70941PS
- HY-B1410
- Tox21_110709
- 1,3-Benzenedicarboxamide, N,N'-bis(2,3-dihydroxypropyl)-5-((hydroxyacetyl)(2-hydroxyethyl)amino)-2,4,6-triiodo-
- AC-536
- AR-1K1129
- EBC-27477
- NSC760064
- s5013
- AKOS015896385
- Tox21_110709_1
- C18-H24-I3-N3-O9
- CCG-213209
- CS-7483
- DB09134
- FI24641
- NSC-760064
- NCGC00016956-01
- NCGC00179364-01
- NCGC00179364-03
- AN-15742
- AS-12851
- BC215938
- J33.102C
- LS-29726
- SID:134222801
- CAS-87771-40-2
- AB00513943
- FT-0627284
- NS00008942
- P 530
- 1-N,3-N-bis(2,3-dihydroxypropyl)-5-[(2-hydroxyacetyl)-(2-hydroxyethyl)amino]-2,4,6-triiodobenzene-1,3-dicarboxamide
- D01555
- G12764
- AB00513943_02
- 771I402
- A842365
- C054871
- EN300-19767831
- N,N'-Bis(2,3-dihydroxypropyl)-5-(N-(2-hydroxyethyl)glycolamido)-2,4,6-triiodoisophthalamide
- SR-01000872680
- I06-1983
- Q6064187
- SR-01000872680-1
- BRD-A65818372-001-01-2
- BRD-A65818372-001-05-3
- N1,N3-bis(2,3-dihydroxypropyl)-5-(2-hydroxy-N-(2-hydroxyethyl)acetamido)-2,4,6-triiodoisophthalamide
- 8771-40-2
- n,n'-bis(2,3-dihydroxypropyl)-5-[glycoloyl(2-hydroxyethyl)amino]-2,4,6-triiodoisophthalamide
- N,N'-bis(2,3-dihydroxypropyl)-5-[(hydroxyacetyl)(2-hydroxyethyl)amino]-2
- N1,N3-bis(2,3-dihydroxypropyl)-5-[(2-hydroxyacetyl)-(2-hydroxyethyl)amino]-2,4,6-triiodo-benzene-1,3-dicarboxamide
- N1,N3-bis(2,3-dihydroxypropyl)-5-[2-hydroxy-N-(2-hydroxyethyl)acetamido]-2,4,6-triiodobenzene-1,3-dicarboxamide
- 1,3-Benzenedicarboxamide, N1,N3-bis(2,3-dihydroxypropyl)-5-[(2-hydroxyacetyl)(2-hydroxyethyl)amino]-2,4,6-triiodo-
- 93840-78-9
- N,N -Bis(2,3-dihydroxypropyl)-5-[(2-hydroxyethyl)(hydroxyacetyl)amino]-2,4,6-triiodoisophthalamide
- N,N -bis(2,3-dihydroxypropyl)-5-[N-(2-hydroxyethyl)-glycolamidol]-2,4,6-triiodoisophthalamide
- N,N'-Bis (2,3-dihydroxypropyl)-5-[N-(2-hydroxyethyl) -glycolamido] -2,4,6-triiodoisophthalamide
- N,N'-bis(2,3-dihydroxypropyl)-5-[(hydroxyacetyl)(2-hydroxyethyl)amino]-2-1,3-benzenedicarboxamide
- N~1~,N~3~-Bis(2,3-dihydroxypropyl)-5-[2-hydroxy-N-(2-hydroxyethyl)acetamido]-2,4,6-triiodobenzene-1,3-dicarboxamide
- N1,N3-bis(2,3-dihydroxypropyl)-5-(2-hydroxy-N-(2-hydroxyethyl)acetamido)-2,4,6-triiodobenzene-1,3-dicarboxamide